Seed financing led by Kickstart will accelerate causal genomics platform development and the company’s first commercial Atlas. Genomic AI needs more than DNA sequences. It needs to learn from what genetic changes actually do in human cells” — Ryan T. Gill, Co-Founder and CEO, Codebreaker Labs BOULDER, CO, UNITED STATES — Codebreaker Labs today announced the [...]

NHS England has announced a major pilot of rapid genomic testing for brain tumours, using Oxford Nanopore sequencing alongside specialist analysis software developed at the University of Nottingham. Building on work in Nottingham and Birmingham, the programme will extend testing across specialist centres in England, evaluating how rapid genomic analysis can be delivered at scale. [...]

New portfolio combines high-performance cell culture media, molecule-specific CQA optimization, and integrated CDMO capabilities to help biosimilar developers accelerate the path to analytical similarity and improve process economics. PLEASANTON, Calif. -- OPM Biosciences, a cell culture media and bioprocess solutions company, today announced two new offerings that extend its OPM-CHO™ platform into biosimilar development and [...]

Record-setting Bio-Silicon Chip is first to create Synthetic DNA at IT Scale for Molecular Computing solutions addressing growing demands of the AI Era SAN FRANCISCO -- AtlasBase today announced its molecular computing platform, powered by Thalia, a new scalable chip that delivers petabyte-scale synthetic DNA creation. With 5.6 billion electro-chemical synthesis sites, Thalia represents a [...]

Model-agnostic platform enables researchers to build and deploy custom AI scientist agents within Federated Trusted Research Environments London, UK -- Lifebit, a leading provider of secure biomedical data platforms and Trusted Research Environments (TREs), has announced the launch of AI Scientist Studio at HumanX Amsterdam. The new platform enables researchers to build and deploy custom AI [...]

Industry’s First End-to-End Flow Cytometry Platform Covering Panel Design Through Data Analysis FREMONT, Calif. -- Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the expansion of its Cytek® Cloud digital ecosystem with a new Cloud Analysis tool, establishing the industry’s first end-to-end platform that integrates the entire flow cytometry workflow from panel [...]

New cGMP-ready media and feed panel helps developers rapidly identify high-performing combinations, with study results demonstrating up to 73% higher titer versus benchmark catalog media and feeds and up to 202% higher peak viable cell density compared with benchmark products tested Key facts Product: Gibco™ CHO-K1 Catalog Panel Media and Feed Category: Basal and feed [...]

ROCKVILLE, Md. -- MaxCyte, Inc. (Nasdaq: MXCT), a leading cell engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it has appointed Sidharth Kapileshwar as Chief Corporate Development Officer. "Sidharth has a proven track record of building and scaling corporate development functions inside some [...]

MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) ("Bio-Techne"), a global provider of life science tools, reagents and diagnostic products, announced that Bio-Techne shareholders voted to approve and adopt the definitive agreement under which Merck KGaA, Darmstadt, Germany proposes to acquire Bio-Techne (the "Merger Agreement") at a Special Meeting of Shareholders held today. "We are grateful to our [...]

The acquisition will help expand AVS Bio's biomaterials offering and ecommerce capabilities NORWICH, Conn. -- AVS Bio (the "Company"), a leading global provider of critical inputs and services for the bioprocessing and biologics industries, today announced it has acquired Biorbyt Ltd. ("Biorbyt"), a global supplier of high-quality bio-reagents, antibodies, proteins, and other biomaterials for life [...]